News Chart Sienna Biopharmaceuticals, Inc.

Equities

SNNAQ

US82622H1086

Market Closed - OTC Markets Other stock markets 17:16:25 10/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc.	CI
2021	Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million.	CI

d149ed7c488f44c4341611.tZBQzcFHWGnYkk46t8IHYXhzxjc13HAsUjaYIl2aB_4.4fEVvqtzPw-g9BsP4KhQLiFeoQFXqQpHJUf1bjb0TLPt3gCKkDV1GLnUHw~ffed3443ac1edd70850facb2e812ef10